We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Two New Rapid Tests Detect Ricin

By LabMedica International staff writers
Posted on 15 Apr 2009
New tests for ricin have been developed independently by two groups of scientists. More...
These tests could help safeguard people against potential acts of terrorism involving ricin and also have medical implications.

Ricin, a ribosomal inactivating protein found in castor beans, is one of the agents most likely to be used in acts of aerosol or food-related bioterrorism. It can be obtained easily, and quickly causes death when inhaled or eaten in small amounts. There is no known antidote. Quantitation of ricin also has medical applications, because ricin immunoconjugates have been used as anticancer agents. Current tests capable of identifying ricin by protein recognition methods exist but are generally slow, cumbersome, and inaccurate.

Vern Schramm and Matthew Sturm at the department of biochemistry, Albert Einstein College of Medicine of Yeshiva University (Bronx, NY, USA) developed a new test that detects the presence of active ricin in any sample by measuring the release of adenine from specific ricin substrates. Ricin-catalyzed adenine release from ribosomes stops protein synthesis and is the mechanism of action of this deadly toxin. By coupling adenine release to light formation by firefly luciferase, scientists can visualize the presence of ricin by the simple detection of light. The test can detect nanogram (one-billionth of a gram) amounts of ricin in minutes. A report of this test appeared online in the March 20, 2009 edition of Analytical Chemistry.

A highly selective three-part test was developed by John Barr and Suzanne Kalb from the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA). The test involves capturing the ricin protein using special antibodies, evaluating the enzymatic activity of the ricin protein by mass spectrometry, and identifying the ricin protein by its amino acid sequence through mass spectrometry. In laboratory tests using small amounts of ricin spiked into food and body fluids, including milk, apple juice, serum, and saliva, the scientists found that the test was highly specific and accurate in comparison to current tests. This study appeared online in the February 19, 2009 publication of Analytical Chemistry.

Related Links:

Albert Einstein College of Medicine of Yeshiva University
United States Centers for Disease Control and Prevention




New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.